Diastika Biotekindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 21.7× Diastika Biotekindo Tbk.'s market cap, and Diastika Biotekindo Tbk. is more actively traded (1.22M versus 613K). Which is the better fit depends on your goals.
| CHEK | TSPC | |
|---|---|---|
Market Cap | 514.17B | 11.18T |
Volume | 1.22M | 613K |
Lot | 12.25K | 6.13K |
Turnover | 155.6M | 1.54B |
Average Price | 127.05 | 2,511.52 |
Value | 155.6M | 1.54B |
Indicative Equilibrium Price | 126 | 2,520 |
Indicative Equilibrium Volume | 503 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →